Telix Pharmaceuticals Limited (TLX) Earnings History
Profitable9 years of earnings data (2017–2025) · Positive TTM net income
Loading earnings history...
Telix Pharmaceuticals Limited (TLX) Earnings Overview
As of June 23, 2026, Telix Pharmaceuticals Limited (TLX) reported trailing twelve-month net income of $39M, reflecting -122.6% year-over-year growth. The company earned $0.12 per diluted share over the past four quarters, with a net profit margin of -0.9%.
Looking at the long-term picture, TLX's historical earnings data spans multiple years. The company achieved its highest annual net income of $50M in fiscal 2024.
Telix Pharmaceuticals Limited maintains positive profitability with a gross margin of 53.1%, operating margin of 2.2%, and net margin of -0.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including EXEL ($833M net income, 33.7% margin), RNW ($10.40B net income, 7.9% margin), AGEN ($65M net income, 0.1% margin), TLX has room to improve margins relative to the peer group. Compare TLX vs EXEL →
TLX Earnings vs Peers
Earnings metrics vs comparable public companies
TLX Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$11M | -121.4% | $27M | $-0.03 | -0.9% | 2.2% |
| 2024 | $50M | +858.0% | $82M | $0.14 | 6.4% | 10.5% |
| 2023 | $5M | +105.0% | $16M | $0.02 | 1.0% | 3.2% |
| 2022 | -$104M | -29.3% | -$92M | $-0.34 | -65.0% | -57.4% |
| 2021 | -$81M | -79.4% | -$81M | $-0.29 | -1059.9% | -1069.6% |
| 2020 | -$45M | -61.1% | -$44M | $-0.17 | -861.1% | -847.7% |
| 2019 | -$28M | -101.5% | -$36M | $-0.12 | -799.6% | -1033.6% |
| 2018 | -$14M | -116.9% | -$29M | $-0.07 | -7087.1% | -15016.1% |
| 2017 | -$6M | - | -$7M | $-0.05 | - | - |
Download Data
Export TLX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TLX — Frequently Asked Questions
Quick answers to the most common questions about buying TLX stock.
What is TLX earnings per share (EPS)?
TLX trailing twelve-month (TTM) diluted EPS is $0.12, reflecting -122.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Telix Pharmaceuticals Limited's net income?
Telix Pharmaceuticals Limited (TLX) trailing twelve-month net income is $39M as of 2025. Earnings declined -122.6% year-over-year.
Is TLX profitable?
Yes, TLX is profitable with a TTM net income of $39M and a net profit margin of -0.9%.
What is TLX's earnings growth rate?
TLX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are TLX's profit margins?
Telix Pharmaceuticals Limited net profit margin is -0.9%, operating margin is +2.2%, and gross margin is +53.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is -1.8%.
Is TLX growing earnings?
TLX earnings are declining — EPS fell -122.6% year-over-year. TTM net income dropped to $39M. This contrasts with the 5-year CAGR of N/A.
What was TLX's best earnings year?
Telix Pharmaceuticals Limited's highest annual net income on record is $50M, achieved in fiscal year 2024. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were TLX's earnings last quarter?
TLX's most recent reported quarter was Q4 2025. Net income was $-7M with diluted EPS of $-0.02. For a full breakdown of all quarters, see the quarterly earnings table on this page.